Home » Products » Sulfadoxine/Pyrimethamine 175mg + Amodiaquine 75mg | GMP Manufacturer & Supplier | Sinophare
- Dosage: Sulfadoxine/Pyrimethamine 175 mg and Amodiaquine 75mg
- Packaging: 9 tablets/blister*10/box
- Shelf Life: 36months
Package:
Product Description
| Product Name | Sulfadoxine/Pyrimethamine + Amodiaquine Tablets (Sulfadoxine/Pyrimethamine 175mg + Amodiaquine 75mg Oral Tablets) |
| Specification | Each tablet contains: Sulfadoxine/Pyrimethamine 175mg + Amodiaquine 75mg |
| Dosage Form | Oral Film-Coated Tablet (for oral administration) |
| Active Ingredients | Sulfadoxine / Pyrimethamine / Amodiaquine |
| Pharmacological Class | Antimalarial Combination (Sulfonamide / Antifolate / 4-Aminoquinoline) |
| Route of Administration | Oral administration (swallowed whole with water; take with food to reduce gastrointestinal upset). Take at approximately the same time each day during the treatment course. |
| Packaging | Blister pack (PVC-Alu) or strip pack, typically per treatment course |
| Storage | Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze. |
| Shelf Life | 36 months (unopened) |
Product Overview
This product is an oral antimalarial combination tablet containing Sulfadoxine/Pyrimethamine 175mg and Amodiaquine 75mg per tablet. It combines two classes of antimalarial agents: (a) a long-acting sulfonamide antifolate combination (sulfadoxine/pyrimethamine), and (b) a 4-aminoquinoline derivative (amodiaquine). The combination of two agents with complementary mechanisms of action is designed to provide effective antimalarial activity while also reducing the risk of parasite resistance development. The product is formulated as film-coated tablets for convenient oral administration.
